These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 8222297)

  • 1. Hyperactivity of the hypothalamo-pituitary-adrenal axis in obesity: a study of ACTH, AVP, beta-lipotrophin and cortisol responses to insulin-induced hypoglycaemia.
    Weaver JU; Kopelman PG; McLoughlin L; Forsling ML; Grossman A
    Clin Endocrinol (Oxf); 1993 Sep; 39(3):345-50. PubMed ID: 8222297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of beta-endorphin on basal and insulin-hypoglycaemia stimulated levels of hypothalamic-pituitary-adrenal axis hormones in normal human subjects.
    Inder WJ; Livesey JH; Ellis MJ; Evans MJ; Donald RA
    Clin Endocrinol (Oxf); 1996 Jan; 44(1):7-13. PubMed ID: 8706296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACTH and cortisol response to combined corticotropin releasing hormone-arginine vasopressin stimulation in obese males and its relationship to body weight, fat distribution and parameters of the metabolic syndrome.
    Pasquali R; Gagliardi L; Vicennati V; Gambineri A; Colitta D; Ceroni L; Casimirri F
    Int J Obes Relat Metab Disord; 1999 Apr; 23(4):419-24. PubMed ID: 10340821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothalamic-pituitary-adrenal axis activity and its relationship to the autonomic nervous system in women with visceral and subcutaneous obesity: effects of the corticotropin-releasing factor/arginine-vasopressin test and of stress.
    Pasquali R; Anconetani B; Chattat R; Biscotti M; Spinucci G; Casimirri F; Vicennati V; Carcello A; Labate AM
    Metabolism; 1996 Mar; 45(3):351-6. PubMed ID: 8606643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of the hypothalamic-pituitary-adrenal axis to small dose arginine-vasopressin and daily urinary free cortisol before and after alprazolam pre-treatment differs in obesity.
    Vicennati V; Ceroni L; Gagliardi L; Pagotto U; Gambineri A; Genghini S; Pasquali R
    J Endocrinol Invest; 2004 Jun; 27(6):541-7. PubMed ID: 15717651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal man.
    Inder WJ; Ellis MJ; Evans MJ; Donald RA
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):425-31. PubMed ID: 7586616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormalities of the hypothalamic-pituitary-adrenal axis in nondepressed women with abdominal obesity and relations with insulin resistance: evidence for a central and a peripheral alteration.
    Vicennati V; Pasquali R
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4093-8. PubMed ID: 11095438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of maternal overnutrition and obesity on hypothalamic-pituitary-adrenal axis response of offspring to stress.
    Long NM; Nathanielsz PW; Ford SP
    Domest Anim Endocrinol; 2012 May; 42(4):195-202. PubMed ID: 22264661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: interaction with endogenous opioid peptides.
    Inder WJ; Joyce PR; Ellis MJ; Evans MJ; Livesey JH; Donald RA
    Clin Endocrinol (Oxf); 1995 Sep; 43(3):283-90. PubMed ID: 7586596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothalamo-pituitary-adrenal cortical responses to low-dose physostigmine and arginine vasopressin administration: sex differences between major depressives and matched control subjects.
    Rubin RT; O'Toole SM; Rhodes ME; Sekula LK; Czambel RK
    Psychiatry Res; 1999 Dec; 89(1):1-20. PubMed ID: 10643873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha2-adrenoceptor regulation of the hypothalamic-pituitary-adrenocortical axis in obesity.
    Pasquali R; Vicennati V; Calzoni F; Gnudi U; Gambineri A; Ceroni L; Cortelli P; Menozzi R; Sinisi R; Rio GD
    Clin Endocrinol (Oxf); 2000 Apr; 52(4):413-21. PubMed ID: 10762283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An association between hypothalamic-pituitary dysfunction and peripheral endocrine function in extreme obesity.
    Weaver JU; Noonan K; Kopelman PG
    Clin Endocrinol (Oxf); 1991 Jul; 35(1):97-102. PubMed ID: 1889145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute dexamethasone suppression of ACTH secretion stimulated by human corticotrophin releasing hormone, AVP and hypoglycaemia.
    Hohnloser J; Von Werder K; Müller OA
    Clin Endocrinol (Oxf); 1989 Aug; 31(2):175-84. PubMed ID: 2557988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
    Cleare AJ; Miell J; Heap E; Sookdeo S; Young L; Malhi GS; O'Keane V
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3545-54. PubMed ID: 11502777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ghrelin does not mediate the somatotroph and corticotroph responses to the stimulatory effect of glucagon or insulin-induced hypoglycaemia in humans.
    Broglio F; Prodam F; Gottero C; Destefanis S; Me E; Riganti F; Giordano R; Picu A; Balbo M; Van der Lely AJ; Ghigo E; Arvat E
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):699-704. PubMed ID: 15163333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma cortisol, PRL, ACTH, AVP and corticotrophin releasing hormone responses to direct current cardioversion and electroconvulsive therapy.
    Florkowski CM; Crozier IG; Nightingale S; Evans MJ; Ellis MJ; Joyce P; Donald RA
    Clin Endocrinol (Oxf); 1996 Feb; 44(2):163-8. PubMed ID: 8849570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral glucose tolerance testing but not intravenous glucose administration uncovers hyper-responsiveness of hypothalamo-pituitary-adrenal axis in patients with adrenal incidentalomas.
    Beuschlein F; Borgemeister M; Schirra J; Göke B; Fassnacht M; Arlt W; Allolio B; Reincke M
    Clin Endocrinol (Oxf); 2000 May; 52(5):617-23. PubMed ID: 10792342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-dexamethasone serum copeptin corresponds to HPA axis responsiveness in human obesity.
    Schinke C; Hesse S; Stoppe M; Meyer K; Schmidt E; Orthgiess J; Bechmann L; Bresch A; Rullmann M; Luthardt J; Sabri O; Blüher M; Kratzsch J; Then Bergh F
    Psychoneuroendocrinology; 2017 Apr; 78():39-47. PubMed ID: 28167369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution.
    Pasquali R; Cantobelli S; Casimirri F; Capelli M; Bortoluzzi L; Flamia R; Labate AM; Barbara L
    J Clin Endocrinol Metab; 1993 Aug; 77(2):341-6. PubMed ID: 8393881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comment: response of the hypothalamic-pituitary-adrenocortical axis to high-protein/fat and high-carbohydrate meals in women with different obesity phenotypes.
    Vicennati V; Ceroni L; Gagliardi L; Gambineri A; Pasquali R
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3984-8. PubMed ID: 12161547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.